| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hypertension, Pulmonary | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hypertension | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Lung Diseases | |||||
| Respiratory Tract Diseases | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Heart Catheterization | |||||
| Nitric Oxide | |||||
| Nitric Oxide/INO Pulse Delivery | |||||
| Sodium Nitrite | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Asthmatic Agents | |||||
| Antioxidants | |||||
| Autonomic Agents | |||||
| Bronchodilator Agents | |||||
| Cardiovascular Agents | |||||
| Endothelium-Dependent Relaxing Factors | |||||
| Free Radical Scavengers | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Respiratory System Agents | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institutes of Health Clinical Center (CC) | |||||
|
